Nuvectis Pharma Correlations
| NVCT Stock | USD 5.04 0.24 4.55% |
The current 90-days correlation between Nuvectis Pharma and Kronos Bio is -0.05 (i.e., Good diversification). The correlation of Nuvectis Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Nuvectis Pharma Correlation With Market
Significant diversification
The correlation between Nuvectis Pharma and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and DJI in the same portfolio, assuming nothing else is changed.
Nuvectis |
Moving against Nuvectis Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Nuvectis Stock performing well and Nuvectis Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nuvectis Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| REPL | 3.19 | 0.66 | 0.13 | (2.20) | 3.08 | 8.25 | 46.30 | |||
| LYRA | 4.22 | (0.53) | 0.00 | (0.23) | 0.00 | 10.53 | 41.07 | |||
| KRON | 2.55 | (0.07) | 0.00 | (0.10) | 0.00 | 5.56 | 16.20 | |||
| GOSS | 2.39 | (0.39) | 0.00 | (0.38) | 0.00 | 6.06 | 17.73 | |||
| OLMA | 2.86 | (0.14) | 0.00 | (0.44) | 0.00 | 6.17 | 19.19 | |||
| LRMR | 4.11 | (0.18) | (0.03) | 0.00 | 4.83 | 10.87 | 26.71 | |||
| CNTA | 2.81 | 0.36 | 0.10 | 0.45 | 3.08 | 8.37 | 21.09 | |||
| OBIO | 3.74 | 0.12 | 0.00 | 0.04 | 0.00 | 7.24 | 25.42 | |||
| GLUE | 5.18 | 0.88 | 0.25 | 0.43 | 3.74 | 8.10 | 102.66 | |||
| NAMS | 2.33 | 0.33 | 0.07 | 0.69 | 3.33 | 5.33 | 29.23 |
Nuvectis Pharma Corporate Executives
Elected by the shareholders, the Nuvectis Pharma's board of directors comprises two types of representatives: Nuvectis Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nuvectis. The board's role is to monitor Nuvectis Pharma's management team and ensure that shareholders' interests are well served. Nuvectis Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nuvectis Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shay Shemesh | Executive CoFounder | Profile | |
| Enrique Poradosu | Executive CoFounder | Profile |